BIG
RLAY icon

Brooklyn Investment Group’s Relay Therapeutics RLAY Stock Holding History

Brooklyn Investment Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$324K Buy
32,577
+5,436
+20% +$48.6K 0.01% 1362
2025
Q4 		$228K Sell
27,141
-70,806
-72% -$505K 0.01% 1254
2025
Q3 		$323K Sell
97,947
-3,110
-3% -$11.9K 0.04% 399
2025
Q2 		$350K Buy
101,057
+95,002
+1,569% +$283K 0.05% 387
2025
Q1 		$15.9K Buy
6,055
+3,254
+116% +$12.8K ﹤0.01% 1288
2024
Q4 		$11.5K Buy
+2,801
New +$15.2K ﹤0.01% 933

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Brooklyn Investment Group's RLAY Position: Q1 2026 in Review

Brooklyn Investment Group increased its Relay Therapeutics (RLAY) stake by 20% in Q1 2026, buying an estimated $48.6K and bringing the position to 32,577 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #1362.

Brooklyn Investment Group first reported a position in RLAY in Q4 2024 and has held it in 6 quarters since. The position peaked at $350K in Q2 2025. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Brooklyn Investment Group held 32,577 shares of Relay Therapeutics worth $324K as of Q1 2026.
  • Brooklyn Investment Group bought 5,436 Relay Therapeutics shares in Q1 2026, an estimated $48.6K.
  • Relay Therapeutics made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1362 holding.
  • Brooklyn Investment Group first reported a position in Relay Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Brooklyn Investment Group's Relay Therapeutics position peaked at $350K in Q2 2025.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.